Lexeo Therapeutics raised $95.0 million in an oversubscribed equity financing led by Braidwell LP and Adage Capital Partners LP to fund advancement of ongoing clinical stage programs.
Amount Raised
$95 Million
Round Type
Venture
Investors
Description
Lexeo Therapeutics announced the closing of an oversubscribed equity financing of approximately $95.0 million, co-led by Braidwell LP and Adage Capital Partners LP. The financing also involved participation from new and existing investors including RA Capital Management, Surveyor Capital, Eventide Asset Management, Novo Holdings A/S, Invus, Laurion Capital Management, Longitude Capital, Omega Funds and Woodline Partners LP. The proceeds will be used to fund advancement of ongoing clinical stage programs, and for working capital and general corporate purposes.
Who to call at Lexeo Therapeutics, and when
A new round usually means Lexeo Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Lexeo Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Lexeo Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Lexeo Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Lexeo Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Lexeo Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.